PF-47184 |
RENVELA 800 mg Comprimido recubierto |
2027-04-21 |
|
Genzyme Europe B.V. |
Irlanda
|
Sanofi-Aventis De Guatemala |
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Droguería Y Farmacia Lanquetin |
Agefinsa |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-47791 |
MYOZYME Polvo para concentrado para solución para perfusión |
2028-01-03 |
|
Genzyme Europe B.V. |
Irlanda
|
Sanofi-Aventis De Guatemala |
J.I.Cohen, S.A. |
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49065 |
FABRAZYME 35 mg Polvo liofilizado para uso parenteral |
2023-09-11 |
|
Genzyme Corporation |
Irlanda
|
Sanofi-Aventis De Guatemala |
J.I.Cohen, S.A. |
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49069 |
THYROGEN Polvo liofilizado para uso parenteral |
2028-09-04 |
|
Genzyme Corporation |
Irlanda
|
Sanofi-Aventis De Guatemala |
J.I.Cohen, S.A. |
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38103 |
ISOCRANEOL 100 mg/mL Solución Oral (gotas) |
2016-10-17 |
|
Laboratorios Vizcaíno, S.A. |
Argentina
|
Laboratorios Vizcaíno, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38104 |
ISOCRANEOL 100 mg Comprimidos Recubiertos |
2011-10-17 |
|
Laboratorios Vizcaíno, S.A. |
Argentina
|
Laboratorios Vizcaíno, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38105 |
ISOCRANEOL 1000 mg/5mL Solución inyectable |
2016-10-17 |
|
Laboratorios Vizcaíno, S.A. |
Argentina
|
Laboratorios Vizcaíno, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38126 |
ISOCRANEOL 200 mg Comprimido Recubierto (Simple) |
2016-10-23 |
|
Laboratorios Vizcaíno, S.A. |
Argentina
|
Laboratorios Vizcaíno, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38127 |
ISOCRANEOL 500 mg/2.5mL Solución Inyectable |
2016-10-23 |
|
Laboratorios Vizcaíno, S.A. |
Argentina
|
Laboratorios Vizcaíno, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38338 |
ORALSONE TOPIC Solución Bucal |
2022-01-10 |
|
BMA Pharma, S.A. |
Argentina
|
Leterago |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|